VC  NDI

http://www.ndimedical.com





     Office Locations:

22901 Millcreek Blvd., Suite 110
Cleveland, OH 44122
Phone: 216-378-9106
Fax: 216-378-9116

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2002, NDI is a leading venture capital and commercialization firm that focuses on innovative neurodevice technologies to address significant unmet health conditions. NDI leverages its platform of innovative technologies to commercialize an extensive pipeline of neurotech opportunities, creating high-growth portfolio companies. In April 2008, NDI sold its first portfolio company to Medtronic Inc. for $42 million, returning over 150 times the original investment back to investors. NDI maintains a proprietary technology platform of neurodevices consisting of implantable pulse generators, external pulse generators, leads, surgical deployment tools, external programmers, and patient controllers that can be applied to many different therapeutic applications or adapted for new devices.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Geoffrey B. Thrope Founder and Managing Director
    Joseph Boggs Ph.D. Director
    Leonard M. Cosentino Vice President and General Counsel
    Maria Bennett Vice President
    Mark Stultz Vice President

     

    Portfolio companies include:


      Checkpoint Surgical
        web link


      Deep Brain Innovations
        web link


      MEDSTIM
        web link


      SPR Therapeutics
        web link


     

    Recent News:


      There is no recent news for NDI.